Financial Gravity Asset Management, Inc. Innoviva, Inc. Transaction History

Financial Gravity Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$11.8 - $13.78 $153 - $179	13 New	13 $173,000
Q3 2018 Oct 31, 2018	SELL	$13.63 - $15.7 $272 - $314	-20 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$13.44 - $17.59 $27,955 - $36,587	-2,080 Reduced 99.05%	20 $0
Q1 2018 May 23, 2018	BUY	$13.8 - $16.99 $28,980 - $35,679	2,100 New	2,100 $30,000

228

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.21B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.